MSA
ZBH icon

Marino Stram & Associates’s Zimmer Biomet ZBH Stock Holding History

Marino Stram & Associates’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,845
Closed -$288K – 297
2021
Q2 		$288K Buy
+1,845
New +$299K 0.08% 213
2019
Q2 		– Sell
-55
Closed -$7K – 583
2019
Q1 		$7K Buy
+55
New +$6.25K 0.01% 334

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Marino Stram & Associates's ZBH Position: Q3 2021 in Review

Marino Stram & Associates sold out of Zimmer Biomet (ZBH) in Q3 2021, closing a stake of 1,845 shares — an estimated $288K sold.

Marino Stram & Associates first reported a position in ZBH in Q1 2019 and held it in 2 quarters. The position peaked at $288K in Q2 2021. 982 funds tracked by Wall St. Rank hold ZBH as of Q3 2021.

  • Marino Stram & Associates reported no remaining Zimmer Biomet position as of Q3 2021 after selling out during the quarter.
  • Marino Stram & Associates sold 1,845 Zimmer Biomet shares in Q3 2021, an estimated $288K.
  • Marino Stram & Associates first reported a position in Zimmer Biomet in Q1 2019 and held it in 2 quarters.
  • Marino Stram & Associates's Zimmer Biomet position peaked at $288K in Q2 2021.
  • 982 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2021.

Based on Marino Stram & Associates's 13F filing for Q3 2021, filed 14 Oct 2021.